{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:42:06Z","timestamp":1788550926666,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00592-013-0493-7","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T07:43:25Z","timestamp":1373269405000},"page":"71-78","source":"Crossref","is-referenced-by-count":55,"title":["Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans"],"prefix":"10.1007","volume":"51","author":[{"given":"R.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Heni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ketterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hatziagelaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Staiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-U.","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"493_CR1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc11-0064","volume":"34","author":"RA Defronzo","year":"2011","unstructured":"Defronzo RA (2011) Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. Diabetes Care 34:789\u2013794. doi: 10.2337\/dc11-0064","journal-title":"Diabetes Care"},{"key":"493_CR2","doi-asserted-by":"crossref","unstructured":"Cincotta AH (2002) Hypothalamic role in the insulin resistance syndrome. Insulin Resistance Syndrome","DOI":"10.3109\/9780203217412-19"},{"key":"493_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-8993(83)90865-X","volume":"273","author":"GA Oltmans","year":"1983","unstructured":"Oltmans GA (1983) Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob\/ob). Brain Res 273:369\u2013373","journal-title":"Brain Res"},{"key":"493_CR4","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1097\/00001756-199711100-00016","volume":"8","author":"S Luo","year":"1997","unstructured":"Luo S, Luo J, Meier AH, Cincotta AH (1997) Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance. NeuroReport 8:3495\u20133499","journal-title":"NeuroReport"},{"key":"493_CR5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/nm1202-798","volume":"8","author":"S Obici","year":"2002","unstructured":"Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376\u20131382. doi: 10.1038\/nm798","journal-title":"Nat Med"},{"key":"493_CR6","first-page":"2132","volume":"118","author":"L Koch","year":"2008","unstructured":"Koch L, Wunderlich FT, Seibler J et al (2008) Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118:2132\u20132147. doi: 10.1172\/JCI31073","journal-title":"J Clin Invest"},{"key":"493_CR7","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1210\/en.2004-0270","volume":"145","author":"C Perrin","year":"2004","unstructured":"Perrin C, Knauf C, Burcelin R (2004) Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145:4025\u20134033. doi: 10.1210\/en.2004-0270","journal-title":"Endocrinology"},{"key":"493_CR8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diacare.19.6.667","volume":"19","author":"AH Cincotta","year":"1996","unstructured":"Cincotta AH, Meier AH (1996) Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects. Diabetes Care 19:667\u2013670. doi: 10.2337\/diacare.19.6.667","journal-title":"Diabetes Care"},{"key":"493_CR9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2337\/diacare.23.8.1154","volume":"23","author":"H Pijl","year":"2000","unstructured":"Pijl H, Ohashi S, Matsuda M et al (2000) Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diabetes Care 23:1154\u20131161. doi: 10.2337\/diacare.23.8.1154","journal-title":"Diabetes Care"},{"key":"493_CR10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/endo-94-4-1077","volume":"94","author":"RM MacLeod","year":"1974","unstructured":"MacLeod RM, Lehmeyer JE (1974) Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94:1077\u20131085","journal-title":"Endocrinology"},{"key":"493_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1210\/endo-86-1-120","volume":"86","author":"CA Birge","year":"1970","unstructured":"Birge CA, Jacobs LS, Hammer CT, Daughaday WH (1970) Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. Endocrinology 86:120\u2013130","journal-title":"Endocrinology"},{"key":"493_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(78)91764-6","volume":"2","author":"LG Sobrinho","year":"1978","unstructured":"Sobrinho LG, Nunes MC, Santos MA, Mauricio JC (1978) Radiological evidence for regression of prolactinoma after treatment with bromocriptine. Lancet 2:257\u2013258","journal-title":"Lancet"},{"key":"493_CR13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1517\/13543784.8.10.1683","volume":"8","author":"Meier Cincotta","year":"1999","unstructured":"Cincotta Meier, Jr Cincotta (1999) Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes. Expert Opin Investig Drugs 8:1683\u20131707. doi: 10.1517\/13543784.8.10.1683","journal-title":"Expert Opin Investig Drugs"},{"key":"493_CR14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0015-0282(16)49291-5","volume":"45","author":"O Serri","year":"1986","unstructured":"Serri O, Beauregard H, Rasio E, Hardy J (1986) Decreased sensitivity to insulin in women with microprolactinomas. Fertil Steril 45:572\u2013574","journal-title":"Fertil Steril"},{"key":"493_CR15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11102-009-0183-1","volume":"12","author":"A Tuzcu","year":"2009","unstructured":"Tuzcu A, Yalaki S, Arikan S et al (2009) Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique. Pituitary 12:330\u2013334. doi: 10.1007\/s11102-009-0183-1","journal-title":"Pituitary"},{"key":"493_CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF03345182","volume":"26","author":"A Tuzcu","year":"2003","unstructured":"Tuzcu A, Bahceci M, Dursun M et al (2003) Insulin sensitivity and hyperprolactinemia. J Endocrinol Invest 26:341\u2013346","journal-title":"J Endocrinol Invest"},{"key":"493_CR17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1126\/science.1132009","volume":"314","author":"GA Lincoln","year":"2006","unstructured":"Lincoln GA, Clarke IJ, Hut RA, Hazlerigg DG (2006) Characterizing a mammalian circannual pacemaker. Science 314:1941\u20131944. doi: 10.1126\/science.1132009","journal-title":"Science"},{"key":"493_CR18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0030-1270440","volume":"119","author":"A Peter","year":"2011","unstructured":"Peter A, Fritsche A, Stefan N et al (2011) Diagnostic value of hemoglobin A1c for Type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes 119:234\u2013237. doi: 10.1055\/s-0030-1270440","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"493_CR19","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2337\/db10-0179","volume":"59","author":"A Peter","year":"2010","unstructured":"Peter A, Kantartzis K, Machann J et al (2010) Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 59:3167\u20133173. doi: 10.2337\/db10-0179","journal-title":"Diabetes"},{"key":"493_CR20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"493_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00252262","volume":"26","author":"T Kadowaki","year":"1984","unstructured":"Kadowaki T, Miyake Y, Hagura R et al (1984) Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26:44\u201349","journal-title":"Diabetologia"},{"key":"493_CR22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1479-828X.2011.01321.x","volume":"51","author":"MJ Tanner","year":"2011","unstructured":"Tanner MJ, Hadlow NC, Wardrop R (2011) Variation of female prolactin levels with menopausal status and phase of menstrual cycle. Aust N Z J Obstet Gynaecol 51:321\u2013324. doi: 10.1111\/j.1479-828X.2011.01321.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"493_CR23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/cs0650457","volume":"65","author":"S Franks","year":"1983","unstructured":"Franks S (1983) Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin Sci 65:457\u2013462","journal-title":"Clin Sci"},{"key":"493_CR24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523\u20131631","journal-title":"Physiol Rev"},{"key":"493_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00273860","volume":"28","author":"G Schernthaner","year":"1985","unstructured":"Schernthaner G, Prager R, Punzengruber C, Luger A (1985) Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 28:138\u2013142","journal-title":"Diabetologia"},{"key":"493_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1152\/physiol.00003.2009","volume":"24","author":"CKL Lam","year":"2009","unstructured":"Lam CKL, Chari M, Lam TKT (2009) CNS regulation of glucose homeostasis. Physiology (Bethesda) 24:159\u2013170. doi: 10.1152\/physiol.00003.2009","journal-title":"Physiology (Bethesda)"},{"key":"493_CR27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nature03439","volume":"434","author":"A Pocai","year":"2005","unstructured":"Pocai A, Lam TKT, Gutierrez-Juarez R et al (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026\u20131031. doi: 10.1038\/nature03439","journal-title":"Nature"},{"key":"493_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00125-008-1187-5","volume":"52","author":"O Tschritter","year":"2009","unstructured":"Tschritter O, Hennige AM, Preissl H et al (2009) Insulin effects on beta and theta activity in the human brain are differentially affected by ageing. Diabetologia 52:169\u2013171. doi: 10.1007\/s00125-008-1187-5","journal-title":"Diabetologia"},{"key":"493_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-10-0913","volume":"164","author":"CEHM Donjacour","year":"2011","unstructured":"Donjacour CEHM, Aziz NA, Fr\u00f6lich M et al (2011) Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls. Eur J Endocrinol 164:363\u2013370. doi: 10.1530\/EJE-10-0913","journal-title":"Eur J Endocrinol"},{"key":"493_CR30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/jcem-38-4-646","volume":"38","author":"DC Parker","year":"1974","unstructured":"Parker DC, Rossmann LG, Vanderlaan EF (1974) Relation of sleep-entrained human prolactin release to REM-NonREM cycles. J Clin Endocrinol Metab 38:646\u2013651. doi: 10.1210\/jcem-38-4-646","journal-title":"J Clin Endocrinol Metab"},{"key":"493_CR31","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1152\/ajpendo.1981.241.5.E355","volume":"241","author":"E Cauter Van","year":"1981","unstructured":"Van Cauter E, L\u2019Hermite M, Copinschi G et al (1981) Quantitative analysis of spontaneous variations of plasma prolactin in normal man. Am J Physiol\u2014Endocrinol Metab 241:E355\u2013E363","journal-title":"Am J Physiol\u2014Endocrinol Metab"},{"key":"493_CR32","first-page":"639","volume":"17","author":"N Ben-Jonathan","year":"1996","unstructured":"Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639\u2013669","journal-title":"Endocr Rev"},{"key":"493_CR33","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.2008-1172","volume":"93","author":"ER Hugo","year":"2008","unstructured":"Hugo ER, Borcherding DC, Gersin KS et al (2008) Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J Clin Endocrinol Metab 93:4006\u20134012. doi: 10.1210\/jc.2008-1172","journal-title":"J Clin Endocrinol Metab"},{"key":"493_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2265.1978.tb03568.x","volume":"9","author":"G Copinschi","year":"1978","unstructured":"Copinschi G, De Laet MH, Brion JP et al (1978) Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity. Clin Endocrinol (Oxf) 9:15\u201326","journal-title":"Clin Endocrinol (Oxf)"},{"key":"493_CR35","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1152\/ajpendo.00156.2005","volume":"290","author":"P Kok","year":"2006","unstructured":"Kok P, Roelfsema F, Langendonk JG et al (2006) Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. Am J Physiol Endocrinol Metab 290:E218\u2013E224. doi: 10.1152\/ajpendo.00156.2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"493_CR36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11695-009-9856-0","volume":"19","author":"B Ernst","year":"2009","unstructured":"Ernst B, Thurnheer M, Schultes B (2009) Basal serum prolactin levels in obesity\u2013unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss. Obes Surg 19:1159\u20131162. doi: 10.1007\/s11695-009-9856-0","journal-title":"Obes Surg"},{"key":"493_CR37","doi-asserted-by":"crossref","first-page":"e31305","DOI":"10.1371\/journal.pone.0031305","volume":"7","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Pijl H, Keenan DM, Veldhuis JD (2012) Prolactin secretion in healthy adults is determined by gender, age and body mass index. PLoS ONE 7:e31305. doi: 10.1371\/journal.pone.0031305","journal-title":"PLoS ONE"},{"key":"493_CR38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1095\/biolreprod41.6.1034","volume":"41","author":"FJ Karsch","year":"1989","unstructured":"Karsch FJ, Robinson JE, Woodfill CJ, Brown MB (1989) Circannual cycles of luteinizing hormone and prolactin secretion in ewes during prolonged exposure to a fixed photoperiod: evidence for an endogenous reproductive rhythm. Biol Reprod 41:1034\u20131046. doi: 10.1095\/biolreprod41.6.1034","journal-title":"Biol Reprod"},{"key":"493_CR39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.1983.tb00019.x","volume":"19","author":"A Bellastella","year":"1983","unstructured":"Bellastella A, Criscuolo T, Mango A et al (1983) Circannual rhythms of plasma luteinizing hormone, follicle-stimulating hormone, testosterone, prolactin and cortisol in prepuberty. Clin Endocrinol (Oxf) 19:453\u2013459","journal-title":"Clin Endocrinol (Oxf)"},{"key":"493_CR40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/46.4.551","volume":"46","author":"AH Garde","year":"2000","unstructured":"Garde AH, Hansen \u00c5M, Skovgaard LT, Christensen JM (2000) Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A1c, IgA, prolactin, and free testosterone in healthy women. Clin Chem 46:551\u2013559","journal-title":"Clin Chem"},{"key":"493_CR41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jcem-51-3-632","volume":"51","author":"E Haus","year":"1980","unstructured":"Haus E, Lakatua DJ, Halberg F et al (1980) chronobiological studies of plasma prolactin in women in Kyushu, Japan, and Minnesota, USA. J Clin Endocrinol Metab 51:632\u2013640. doi: 10.1210\/jcem-51-3-632","journal-title":"J Clin Endocrinol Metab"},{"key":"493_CR42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1530\/acta.0.1090446","volume":"109","author":"H Martikainen","year":"1985","unstructured":"Martikainen H, Tapanainen J, Vakkuri O et al (1985) Circannual concentrations of melatonin, gonadotrophins, prolactin and gonadal steroids in males in a geographical area with a large annual variation in daylight. Acta Endocrinol 109:446\u2013450. doi: 10.1530\/acta.0.1090446","journal-title":"Acta Endocrinol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-013-0493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-013-0493-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-013-0493-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T13:07:01Z","timestamp":1645967221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-013-0493-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1007\/s00592-013-0493-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}